Jean-pierre Van Geertruyden

This study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…

This study tests the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo, a high-risk area. Half receive a full dose and half a half dose, both given as two shots 28 days apart. The goal is to see if the vaccine is safe and …